The World Health Organization says it has eliminated the Pfizer-BioNTech coronavirus vaccine for emergency use, which means that poorer countries could soon have access to the fire already available in Europe and North America.
Each country that has a drug regulatory agency will need to issue its own approval for any COVID-19 vaccine, but countries with poor systems usually rely on the WHO to check for vaccines.
The global body said late Thursday that the decision to issue the first validation of emergency use for a COVID-19 vaccine “opens the door for countries to accelerate their own regulatory approval processes to import and administer the vaccine.”
The UN Health Agency said its analysis found that the Pfizer-BioNTech vaccine, which has already been licensed in the United States, the United Kingdom, the European Union and dozens of other countries, “met the mandatory safety and efficacy criteria set by the WHO. “
The BioNTech-Pfizer vaccine must be kept at ultra-frozen temperatures, a major obstacle for developing countries where the necessary freezers and reliable electricity supply may not be available.
“This requirement makes the vaccine more difficult to use in conditions where ultra-cold chain equipment may not be available or reliably available,” said the WHO, adding that it is working to support countries in evaluating their plans. delivery and preparation for use where possible “
This story was published from an agency stream with no text changes. Only the title has been changed.